/

Lighting

/

Lucira Health

Lucira Health

Lucira Health

Verified Nov 2026

Lighting

·

United States flag

Emeryville, California

·

Since 2013

Lucira Health is a diagnostics company headquartered in Emeryville, California, founded in 2013. It employs roughly 200 to 500 people and was publicly listed on the Nasdaq under the ticker LHDX. The company developed portable, smartphone-connected diagnostic devices for rapid infectious disease testing, serving the medical sector. Its main product was an at-home COVID-19 test kit that delivered molecular-level results in 30 minutes or less. Pfizer acquired the company in April 2023 for $36.4 million through a bankruptcy auction.

Lucira Health

Verified Nov 2026

AT A GLANCE

Founded

2013

Headquarters

United States flag

Emeryville, California

Employees

200-500

Ownership

Publicly traded (NASDAQ: LHDX)

Lucira Health at a glance

Revenue

93.1M

Employees

200-500

Founded

2013

Headquarters

Emeryville, California

Ownership

Publicly traded (NASDAQ: LHDX)

Import activity

31

Industries

Automotive

Electric Vehicles

Medical

Plumbing & Hardware

Industrial Equipment

Consumer Goods

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

31

Named foreign suppliers

3

Top origins

China · Jamaica · Dominican Republic · Mexico

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Lucira Health.

What this tells a buyer

Recent coverage from ad-hoc-news.de reports that Lucira Health's equity was liquidated in March 2026, closing out the company's history.

Its at-home COVID-19 and influenza test was granted FDA Emergency Use Authorization in November 2022 for simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B.

The company was publicly traded on Nasdaq under LHDX from 2021 and reported annual revenue in the range of $93.1 million.

Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026

Overview

Lucira Health is a diagnostics company headquartered in Emeryville, California, founded in 2013. It employs roughly 200 to 500 people and was publicly listed on the Nasdaq under the ticker LHDX. The company developed portable, smartphone-connected diagnostic devices for rapid infectious disease testing, serving the medical sector. Its main product was an at-home COVID-19 test kit that delivered molecular-level results in 30 minutes or less. Pfizer acquired the company in April 2023 for $36.4 million through a bankruptcy auction.

At a glance

Attribute

Detail

Founded

2013

Headquarters

Emeryville, California

Employees

200-500

Revenue

93.1M

Ownership

Publicly traded (NASDAQ: LHDX)

Primary capability

Lighting

What Lucira Health makes

Its at-home COVID-19 and influenza test was granted FDA Emergency Use Authorization in November 2022 for simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B.

Trade and customs footprint

Recent coverage from ad-hoc-news.de reports that Lucira Health's equity was liquidated in March 2026, closing out the company's history. US customs bill-of-lading records list 31 inbound shipments across 3 foreign suppliers, with top origins including China · Jamaica · Dominican Republic · Mexico.

Latest developments

Company details

The company was publicly traded on Nasdaq under LHDX from 2021 and reported annual revenue in the range of $93.1 million. Lucira Health was founded in 2013, has an estimated 200-500 employees, and is headquartered in Emeryville, California.

Frequently asked questions

What does Lucira Health make?

Lucira Health is a diagnostics company headquartered in Emeryville, California, founded in 2013. It employs roughly 200 to 500 people and was publicly listed on the Nasdaq under the ticker LHDX. The company developed portable, smartphone-connected diagnostic devices for rapid infectious disease testing, serving the medical sector. Its main product was an at-home COVID-19 test kit that delivered molecular-level results in 30 minutes or less. Pfizer acquired the company in April 2023 for $36.4 million through a bankruptcy auction.

Where is Lucira Health headquartered?

Lucira Health is headquartered in Emeryville, California (1412 62nd St, Emeryville, California, 94608-2036).

When was Lucira Health founded?

Lucira Health was founded in 2013.

How big is Lucira Health?

Lucira Health has an estimated 200-500 employees, with revenue in the 93.1M range.

Is Lucira Health publicly traded?

Publicly traded (NASDAQ: LHDX). Public financial figures are drawn from its filings.

Does Lucira Health import from overseas suppliers?

US customs bill-of-lading records show 31 inbound shipments for Lucira Health, with top origins including China · Jamaica · Dominican Republic · Mexico.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Emeryville, California (HQ)Headquarters · United States
Emeryville, California (HQ)1412 62nd St, Emeryville, California, 94608-2036, United StatesHeadquarters

Evaluating suppliers like these?

This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.